Register Login

GALECTIN THERAPEUTICS INC (GALT)

Shlevin Harold H. 🟡 adjusted position in 30.0K shares (2 derivative) of GALECTIN THERAPEUTICS INC (GALT) at $5.04 Transaction Date: Jun 26, 2026 | Filing ID: 000061

Full text
Register to leave comments
  • News bot June 30, 2026, 11:24 p.m.

    🔍 Shlevin Harold H. (Executive)

    Company: GALECTIN THERAPEUTICS INC (GALT)

    Report Date: 2026-06-26

    Transaction Summary:

    • Total transactions: 6
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 30,000
    • Total shares sold: 60,000

    Detailed Transactions and Holdings:

    • Acquired 7,732 shares of Common Stock at $1.23 per share (Direct)
      Date: 2026-06-26 | Code: M | equity_swap_involved: false | shares_owned_after: 14,232.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 7,732 shares of Common Stock at $5.0 per share (Direct)
      Date: 2026-06-26 | Code: S | equity_swap_involved: false | shares_owned_after: 6,500.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Acquired 22,268 shares of Common Stock at $1.23 per share (Direct)
      Date: 2026-06-29 | Code: M | equity_swap_involved: false | shares_owned_after: 28,768.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 22,268 shares of Common Stock at $5.04 per share (Direct)
      Date: 2026-06-29 | Code: S | equity_swap_involved: false | shares_owned_after: 6,500.00 | transaction_form_type: 4 | Footnotes: F1, F4
    • Sold 7,732 shares of Stock Option (right to buy) at $1.23 per share (Derivative)
      Date: 2026-06-26 | Code: M | Expires: 2035-01-23 | Exercise: 2025-12-31 | equity_swap_involved: false | shares_owned_after: 52,268.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 22,268 shares of Stock Option (right to buy) at $1.23 per share (Derivative)
      Date: 2026-06-29 | Code: M | Expires: 2035-01-23 | Exercise: 2025-12-31 | equity_swap_involved: false | shares_owned_after: 30,000.00 | transaction_form_type: 4 | Footnotes: F1, F3

    Footnotes:

    • F1: The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29. 2025, as disclosed in the Issuers Quarterly Report on Form 10-Q, filed with the SEC on November 14, 2025
    • F2: The shares were sold in multiple transactions at prices ranging from $5.00 to $5.01. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
    • F3: The options vested 100% on December 31, 2025.
    • F4: The shares were sold in multiple transactions at prices ranging from $5.00 to $5.12. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

Search

News categories